SANGAMO THERAPEUTICS, INCSGMO

SANGAMO THERAPEUTICS, INC Segments Disclosure

10-KFiled Mar 30, 20262 min read
SEGMENT INFORMATION
The Company has identified its Chief Executive Officer as the chief operating decision maker (“CODM”). Management uses one measure of profitability and does not segregate the Company’s business for internal reporting. Operating results and assets are reviewed by the CODM primarily at the consolidated entity level for purposes of making resource allocation decisions and for evaluating financial performance. Accordingly, the Company has a single operating and reportable segment comprising all of the Company’s operations.
The key measure of segment profit and loss that the CODM uses to allocate resources and assess performance is the Company’s net loss. The CODM uses net loss to assess the Company’s ongoing financial needs in relation to current resources in assessing performance and allocating resources.
The table below details the Company’s revenues, significant expenses, and other segment items and reconciles those amounts to the Company’s consolidated net loss as computed under U.S. GAAP in the Consolidated Statements of Operations:
Year Ended December 31,
20252024
Revenues$39,552 $57,800 
Less:
Research and development (*)
57,793 70,289 
General and administrative (*)
30,093 37,827 
Clinical manufacturing operations (*)
50,711 35,345 
Impairment of long-lived assets13,235 5,521 
Stock-based compensation9,079 12,382 
Other segment items (**)
1,573 (5,623)
Net loss$(122,932)$(97,941)
(*) Research and development, general and administrative, and clinical manufacturing operations expenses include depreciation and amortization expense, which is included in the Company’s Consolidated Statements of Cash Flows.
(**) Other segment items include restructuring charges, interest income, other (expense) income, net, and income tax benefit.

Historical Timeline

Fiscal YearFiled
2025Mar 30, 2026Showing above
2024Mar 17, 2025

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.

Other Available Disclosures

Income TaxesRevenueFair ValuePP&ECommitmentsStock CompensationNew Standards